ThirdAgeADHD medications won't increase adults' heart risks, says studyCBS NewsThat sounded an alarm among researchers who thought those increases might lead to more heart attacks, strokes, or heart failure among pill-takers. "There had be…
Bone marrow and blood stem cell transplant survival rates equal, when donor is … – PhysOrg.com
Bone marrow and blood stem cell transplant survival rates equal, when donor is …PhysOrg.comPatients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likely to have graft…
Human Herpesvirus 8 in Corneal Endotheliitis Resulting in Graft Failure After … – Archives of Ophthalmology
Human Herpesvirus 8 in Corneal Endotheliitis Resulting in Graft Failure After …Archives of OphthalmologyAlthough corneal allograft rejection after penetrating keratoplasty responds to corticosteroids, in some edematous grafts, herpes simplex virus, v…
Effective Response Rates of Lenalidomide and Rituximab as Initial Treatment of … – Monthly Prescribing Reference
Effective Response Rates of Lenalidomide and Rituximab as Initial Treatment of …Monthly Prescribing ReferenceSAN DIEGO, CA—Investigators at the 53 rd American Society of Hematology Annual Meeting and Exposition presented study data demonstrating hi…
Impact of Nephrologic Care in the Early Management of Chronic Kidney Disease … – Archives of Internal Medicine
Impact of Nephrologic Care in the Early Management of Chronic Kidney Disease …Archives of Internal MedicineWe appreciate the comments of the letter writers, all of whom pointed toward an important, perhaps the most important, goal of earlier nephrolo…
Celgene's Revlimid Delays Cancer Progression in Study – BusinessWeek
Celgene's Revlimid Delays Cancer Progression in StudyBusinessWeekThe 459-patient study focused on patients ages 75 and younger who were ineligible for stem-cell transplant, a way of treating the bone marrow cancer. Celgene is applying for approval …
NewYork-Presbyterian/Columbia surgeons perform first 'ex vivo' lung … – EurekAlert (press release)
NewYork-Presbyterian/Columbia surgeons perform first 'ex vivo' lung …EurekAlert (press release)The Hospital has been on the forefront of developing and improving anti-rejection medications (immunosuppressants), minimally invasive surgery for …
Immunomedics Says SC Veltuzumab Produced High Response Rate In Relapsed ITP – NASDAQ
Immunomedics Says SC Veltuzumab Produced High Response Rate In Relapsed ITPNASDAQResponses occurred across all doses tested, including the lowest dose at 80 mg, regardless of the route of administration, history of splenectomy or prior use of rituximab…
Bone marrow and blood stem cell transplant survival rates equal, when donor is … – EurekAlert (press release)
Bone marrow and blood stem cell transplant survival rates equal, when donor is …EurekAlert (press release)Patients who receive a blood stem cell transplant from a donor outside of their family to treat leukemia and other blood diseases are more likel…
Seattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS … – TradersHuddle.com (press release)
SunHerald.comSeattle Genetics and Millennium Highlight Pivotal Data on ADCETRIS …TradersHuddle.com (press release)ADCETRIS was granted accelerated approval by the US Food and Drug Administration in August 2011 for two indications: (1) the treatment o…